Effect of the ati Gene Deletion on the Pathogenicity and Immunogenicity of the Vaccinia Virus
Copyright ® 2023 National Research University Higher School of Economics..
Among the nonvirion proteins of the vaccinia virus (VACV), a 94-kDa long protein is most abundantly present; the protein is a truncated form of the 150-kDa A-type inclusion (ATI) protein of the cowpox virus encoded by the ati gene. This VACV protein does not form intracellular ATIs, being as it is a major immunogen upon infection/immunization of humans or animals with the VACV. Antibodies specific to this protein are not virus-neutralizing. The present study focused on the effect of the production of this nonstructural major immunogenic VACV protein on the manifestation of pathogenicity and immunogenicity of the virus in the BALB/c mouse model of infection. In order to introduce a targeted deletion into the VACV LIVP genome, the recombinant integration/deletion plasmid pΔati was constructed and further used to generate the recombinant virus LIVPΔati. The pathogenicity of the VACV LIVP and LIVPΔati strains was studied in 3-week-old mice. The mice were intranasally infected with the viruses at a dose of 107 pfu; 50% of the animals infected with the parent LIVP strain died, while infection with the LIVPΔati strain led to the death of only 20% of the mice. Intradermal vaccination of mice aged 6- weeks with the LIVPΔati virus statistically significantly increased the production of VACV-specific IgG, compared to that after intradermal vaccination with VACV LIVP. Meanwhile, no differences were noted in the cell-mediated immune response to the vaccination of mice with VACV LIVP or LIVPΔati, which was assessed by ELISpot according to the number of splenocytes producing IFN-γ in response to stimulation with virus-specific peptides. Intranasal infection of mice with lethal doses of the cowpox virus or the ectromelia virus on day 60 post-immunization with the studied VACV variants demonstrated that the mutant LIVPΔati elicits a stronger protective response compared to the parent LIVP.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:15 |
|---|---|
| Enthalten in: |
Acta naturae - 15(2023), 3 vom: 26. Juli, Seite 82-90 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Yakubitskiy, S N [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Ati gene |
|---|
| Anmerkungen: |
Date Revised 02.11.2023 published: Print Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.32607/actanaturae.17872 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM364006846 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM364006846 | ||
| 003 | DE-627 | ||
| 005 | 20231226094541.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.32607/actanaturae.17872 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1213.xml |
| 035 | |a (DE-627)NLM364006846 | ||
| 035 | |a (NLM)37908769 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Yakubitskiy, S N |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Effect of the ati Gene Deletion on the Pathogenicity and Immunogenicity of the Vaccinia Virus |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 02.11.2023 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a Copyright ® 2023 National Research University Higher School of Economics. | ||
| 520 | |a Among the nonvirion proteins of the vaccinia virus (VACV), a 94-kDa long protein is most abundantly present; the protein is a truncated form of the 150-kDa A-type inclusion (ATI) protein of the cowpox virus encoded by the ati gene. This VACV protein does not form intracellular ATIs, being as it is a major immunogen upon infection/immunization of humans or animals with the VACV. Antibodies specific to this protein are not virus-neutralizing. The present study focused on the effect of the production of this nonstructural major immunogenic VACV protein on the manifestation of pathogenicity and immunogenicity of the virus in the BALB/c mouse model of infection. In order to introduce a targeted deletion into the VACV LIVP genome, the recombinant integration/deletion plasmid pΔati was constructed and further used to generate the recombinant virus LIVPΔati. The pathogenicity of the VACV LIVP and LIVPΔati strains was studied in 3-week-old mice. The mice were intranasally infected with the viruses at a dose of 107 pfu; 50% of the animals infected with the parent LIVP strain died, while infection with the LIVPΔati strain led to the death of only 20% of the mice. Intradermal vaccination of mice aged 6- weeks with the LIVPΔati virus statistically significantly increased the production of VACV-specific IgG, compared to that after intradermal vaccination with VACV LIVP. Meanwhile, no differences were noted in the cell-mediated immune response to the vaccination of mice with VACV LIVP or LIVPΔati, which was assessed by ELISpot according to the number of splenocytes producing IFN-γ in response to stimulation with virus-specific peptides. Intranasal infection of mice with lethal doses of the cowpox virus or the ectromelia virus on day 60 post-immunization with the studied VACV variants demonstrated that the mutant LIVPΔati elicits a stronger protective response compared to the parent LIVP | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a ati gene | |
| 650 | 4 | |a immunogenicity | |
| 650 | 4 | |a intradermal injection | |
| 650 | 4 | |a orthopoxviruses | |
| 650 | 4 | |a protectivity | |
| 650 | 4 | |a vaccinia virus | |
| 700 | 1 | |a Sergeev, A A |e verfasserin |4 aut | |
| 700 | 1 | |a Titova, K A |e verfasserin |4 aut | |
| 700 | 1 | |a Shulgina, I S |e verfasserin |4 aut | |
| 700 | 1 | |a Starostina, E V |e verfasserin |4 aut | |
| 700 | 1 | |a Borgoyakova, M B |e verfasserin |4 aut | |
| 700 | 1 | |a Karpenko, L I |e verfasserin |4 aut | |
| 700 | 1 | |a Shchelkunov, S N |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Acta naturae |d 2009 |g 15(2023), 3 vom: 26. Juli, Seite 82-90 |w (DE-627)NLM218223943 |x 2075-8251 |7 nnns |
| 773 | 1 | 8 | |g volume:15 |g year:2023 |g number:3 |g day:26 |g month:07 |g pages:82-90 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.32607/actanaturae.17872 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 15 |j 2023 |e 3 |b 26 |c 07 |h 82-90 | ||